Katerina Baou*, Vasiliki Katsi, Thomas Makris and Dimitris Tousoulis Pages 1 - 11 ( 11 )
Approximately, half a century has passed since the discovery of beta blockers. Then, their prime therapeutic purpose was to treat angina and cardiac arrhythmias, nowadays, beta blockers’ usage and effectiveness is extended to treat other cardiovascular diseases, such as hypertension, congestive heart failure, and coronary artery disease. Safety concerns were raised about beta blockers and their use for chronic obstructive pulmonary disease (COPD) patients with concurrent cardiovascular disease. After a thorough research of the literature, this review summarizes the evidence proving that beta blockers not only might be well tolerated in COPD patients, but they might also have a beneficial effect in this group of patients.
Beta-blockers, chronic obstructive pulmonary disease, exacerbations COPD, exacerbations cardiovascular disease, heart failure, lung function
First Department of Pulmonary Medicine, Sismanoglio Hospital, Sismanogliou 1, Marousi,, First Department of Cardiology, Hippokration Hospital, University of Athens, Vasilissis Sofias 114, Athens,, Department of Cardiology, Helena Venizelou Hospital, Helenas Venizelou 2 Square, Ampelokipi,, First Department of Cardiology, Hippokration Hospital, University of Athens, Vasilissis Sofias 114, Athens